These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25850789)

  • 21. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate.
    Curti E; Seid CA; Hudspeth E; Center L; Rezende W; Pollet J; Kwityn C; Hammond M; Matsunami RK; Engler DA; Hotez PJ; Elena Bottazzi M
    Hum Vaccin Immunother; 2014; 10(7):1914-25. PubMed ID: 25424799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopathology and modulation induced by hookworms: From understanding to intervention.
    Mourão Dias Magalhães L; Silva Araújo Passos L; Toshio Fujiwara R; Lacerda Bueno L
    Parasite Immunol; 2021 Feb; 43(2):e12798. PubMed ID: 33012113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines.
    Pearson MS; Tribolet L; Cantacessi C; Periago MV; Valero MA; Jariwala AR; Hotez P; Diemert D; Loukas A; Bethony J
    J Allergy Clin Immunol; 2012 Jul; 130(1):13-21. PubMed ID: 22742835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The control of helminths: nonreplicating infectious agents of man.
    Warren KS
    Annu Rev Public Health; 1981; 2():101-5. PubMed ID: 6890842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hookworm vaccines.
    Diemert DJ; Bethony JM; Hotez PJ
    Clin Infect Dis; 2008 Jan; 46(2):282-8. PubMed ID: 18171264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Search for protective antigens of hookworms].
    Wiśniewski M; Długosz E; Baska P; Wedrychowicz H
    Wiad Parazytol; 2006; 52(4):271-6. PubMed ID: 17432617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How do disease control measures impact spatial predictions of schistosomiasis and hookworm? The example of predicting school-based prevalence before and after preventive chemotherapy in Ghana.
    Kulinkina AV; Farnham A; Biritwum NK; Utzinger J; Walz Y
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011424. PubMed ID: 37327211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the air pouch model to investigate immune responses to a hookworm vaccine containing the Na-ASP-2 protein in rats.
    Mendez S; D' Samuel A; Antoine AD; Ahn S; Hotez P
    Parasite Immunol; 2008 Jan; 30(1):53-6. PubMed ID: 18086017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human anthelminthic vaccines: Rationale and challenges.
    Hotez PJ; Strych U; Lustigman S; Bottazzi ME
    Vaccine; 2016 Jun; 34(30):3549-55. PubMed ID: 27171753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hookworm infection and disease: advances for control.
    Albonico M; Savioli L
    Ann Ist Super Sanita; 1997; 33(4):567-79. PubMed ID: 9616967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hookworm infections in human and laboratory animals--differences and similarities in immune responses.
    Długosz E
    Wiad Parazytol; 2005; 51(3):219-25. PubMed ID: 16913526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies.
    Plieskatt JL; Rezende WC; Olsen CM; Trefethen JM; Joshi SB; Middaugh CR; Hotez PJ; Bottazzi ME
    Hum Vaccin Immunother; 2012 Jun; 8(6):765-76. PubMed ID: 22495115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunology of experimental and natural human hookworm infection.
    Gaze S; Bethony JM; Periago MV
    Parasite Immunol; 2014 Aug; 36(8):358-66. PubMed ID: 25337625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neglected tropical disease vaccines.
    Hotez PJ; Brown AS
    Biologicals; 2009 Jun; 37(3):160-4. PubMed ID: 19278869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Vaccines for the World's Poorest People.
    Hotez PJ; Bottazzi ME; Strych U
    Annu Rev Med; 2016; 67():405-17. PubMed ID: 26356803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hookworm infection: Toward development of safe and effective peptide vaccines.
    Shalash AO; Hussein WM; Skwarczynski M; Toth I
    J Allergy Clin Immunol; 2021 Dec; 148(6):1394-1419.e6. PubMed ID: 34872650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of rats against nippostrongylus brasiliensis with worm antigens by oral administration.
    Poulain J; Pery P; Luffau G
    Ann Immunol (Paris); 1976; 127(2):209-13. PubMed ID: 945711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting hookworm, Chagas, and other neglected diseases.
    Health Aff (Millwood); 2011 Jun; 30(6):1088. PubMed ID: 21653961
    [No Abstract]   [Full Text] [Related]  

  • 39. Secretory IgA and complement levels in patients with hookworm infection in Zaria.
    Musa BO; Onyemelukwe GC
    Afr J Med Med Sci; 2000 Jun; 29(2):111-4. PubMed ID: 11379439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A step forward in the journey towards hookworm vaccines.
    Keiser J; Bouchery T
    Lancet Infect Dis; 2024 Jul; 24(7):673-674. PubMed ID: 38513685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.